Net sales at NuVasive Inc increased 5.8% in the first quarter of 2023 compared with the same quarter last year, according to a press release.NuVasive made $307.7 million in net sales, ultimately pulling in a gross profit of $221.3 million. The company said adoption of its new products and higher procedural volumes in the U.S. drove total net sales in 2023.